Skip to main content
. Author manuscript; available in PMC: 2021 Apr 11.
Published in final edited form as: Lancet. 2020 Mar 20;395(10231):1217–1224. doi: 10.1016/S0140-6736(20)30611-5

Table 2:

Efficacy analysis by age group

Children (aged <18 years; n=225) Adults (aged 18–65 years; n=l86) Older adults (aged >65 years; n=51)
Levetiracetam 85 71 19
 Primary outcome 44 (52%; 41–62) 31 (44%; 33–55) 7 (37%; 19–59)
 Probability treatment is the most effective 0.37 0.22 0.22
 Probability treatment is the least effective 0.27 0.44 0.40
Fosphenytoin 71 54 17
 Primary outcome 35 (49%; 38–61) 25 (46%; 34–59) 6 (35%; 17–59)
 Probability treatment is the most effective 0.22 0.41 0.19
 Probability treatment is the least effective 0.47 0.27 0.46
Valproate 69 61 15
 Primary outcome 36 (52%; 41–63) 28 (46%; 34–58) 7 (47%; 25–70)
 Probability treatment is the most effective 0.41 0.37 0.59
 Probability treatment is the least effective 0.26 0.29 0.14

Data are n, n (%; 95% credible interval), or probability.